A UMass Medical School pharmacy expert says the delay in the results of a trial on proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors is frustrating for prescribers waiting to give the drugs to patients with uncontrolled cholesterol levels, according to an article in Specialty Pharmacy Continuum.
UMass Medical School health policy experts will discuss Affordable Care Act (ACA) and Medicaid waivers and newly issued federal guidance at an event June 28 sponsored by the Connecticut Health Foundation in collaboration with the Universal Health Care Foundation of Connecticut.
UMass Medical School experts will present on the role of quality improvement and competency-based education in expanding and improving the health care workforce at the National AHEC Organization conference June 27-30 in Washington, D.C.
A UMass Medical School practice transformation expert says a team-based approach to primary care was key to some early managed care models and has been integrated in primary care, pediatrics and geriatrics for some time, according to an article on the transition to team-based care in Worcester Business Journal.
UMass Medical School experts will present on a variety of topics, including practice transformation, perioperative surgical home care, new medications for hepatitis C and behavioral health integration, at the annual AcademyHealth Research Meeting June 25-28 in Boston.
A study initiated at UMass Medical School and led by Brandeis University highlights unmet needs and barriers to care for women with physical disabilities during pregnancy and childbirth, including clinicians’ knowledge and attitudes and accessibility to health care facilities and equipment. The researchers said clinicians need training to better care for pregnant women with physical disabilities.
The United States Office of National Drug Control Policy has invited a UMass Medical School Health and Criminal Justice Program leader to speak at an event about substance use disorder treatments for justice-involved populations at the Eisenhower Executive Office Building in Washington, D.C., June 17.
A UMass Medical School pharmacy expert believes providers will wait for the results of more cardiovascular outcomes trials before prescribing proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors to manage their patients’ cholesterol levels, according to an article in Pharmacy Practice News.
A UMass Medical School study of Massachusetts Medicaid members suggests certain patients with hepatitis C face barriers to receiving the newest medications to treat the virus. The research paper published in the June edition of the Journal of Managed Care & Specialty Pharmacy says more patients must have access to the life-saving regimens.
Children with intellectual and developmental disabilities may face more risk factors for obesity than typically developing youths, but few studies have focused on obesity in those with disabilities, a researcher in UMass Medical School’s Eunice Kennedy Shriver Center told MedPage Today.
Medical interpreters from throughout New England can choose from 15 workshops, including one on understanding the Zika virus, and listen to a keynote on serving vulnerable populations at the 11th annual Paving the Way to Health Care Access Conference June 10 at the Courtyard Marriott in Marlborough.
A UMass Medical School clinical consultant pharmacist says value-based contracts for proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, a new class of cholesterol-lowering drugs, will lead to lower prices and help patients decrease cholesterol levels, according to an article in Specialty Pharmacy Continuum about an agreement Cigna has reached with Amgen and Sanofi/Regeneron.
Abigail R. Averbach has a longstanding enthusiasm for integrating and exposing health data for decision-makers, and she has found her niche at UMass Medical School developing information to answer important questions for clients, such as the fiscal impact of community-based care versus institutional care for elders.
Community-based organizations play a critical role in enrolling the remaining uninsured in publicly subsidized health insurance and promoting consumer self-sufficiency, according to a report authored by UMass Medical School and released by the Blue Cross Blue Shield of Massachusetts Foundation (BCBSMA Foundation).
Amid laughter and smiles, a team from UMass Medical School’s Work Without Limits program popped green water balloons labeled “Burst the Stigma” as part of a mental health awareness campaign created by the Speaking of Hope recovery community. Work Without Limits released the video May 31 in honor of Mental Health Month.